Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Value of Fecal Lactate and the Fecal-to-Serum Lactate Gradient in Resuscitation Response Among Critically Ill Patients With Tissue Hypoperfusion: A Prospective Pilot Study.

NCT07658001 is registered in ClinicalTrials.gov with Hospital H+ Queretaro as lead sponsor.

NCT NCT07658001
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07658001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Value of Fecal Lactate and the Fecal-to-Serum Lactate Gradient in Resuscitation Response Among Critically Ill Patients With Tissue Hypoperfusion: A Prospective Pilot Study.
Lead sponsor
Hospital H+ Queretaro
Phase
Observational
Overall status
Active, not recruiting
Start date
April 6, 2026
Completion date
December 1, 2026
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, sepsis, shock, tissue hypoperfusion